Nanoscale imaging agents work by interacting with targeted biological structures to improve contrast and clarity in imaging. These agents can be engineered to bind specifically to certain biomolecules, such as proteins or DNA, or to accumulate in specific types of cells, such as cancer cells. When used in imaging techniques like MRI, CT scans, or fluorescence microscopy, these agents enhance the visibility of the structures of interest.
